Free Trial

Nihon Kohden (OTCMKTS:NHNKY) Trading Up 0% - Should You Buy?

Nihon Kohden logo with Medical background

Key Points

  • Nihon Kohden shares experienced a slight increase of 0%, trading at $11.86, with a total of 4,037 shares exchanged, down 43% from the average trading volume.
  • The company reported quarterly earnings with a net margin of 5.77%, and revenue totaling $346.24 million, translating to an EPS of $0.01.
  • Nihon Kohden has a market capitalization of $2.03 billion and operates in the medical equipment sector with products including patient monitoring systems and defibrillators.
  • Five stocks to consider instead of Nihon Kohden.

Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report)'s share price rose 0% during mid-day trading on Tuesday . The stock traded as high as $11.93 and last traded at $11.86. Approximately 4,037 shares were traded during mid-day trading, a decline of 43% from the average daily volume of 7,108 shares. The stock had previously closed at $11.86.

Nihon Kohden Trading Down 1.6%

The company's 50 day moving average is $11.68 and its 200-day moving average is $12.40. The company has a market capitalization of $1.99 billion, a P/E ratio of 21.54 and a beta of 0.40.

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported $0.01 EPS for the quarter. Nihon Kohden had a net margin of 5.77% and a return on equity of 6.74%. The company had revenue of $346.24 million for the quarter.

Nihon Kohden Company Profile

(Get Free Report)

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers.

Read More

Should You Invest $1,000 in Nihon Kohden Right Now?

Before you consider Nihon Kohden, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nihon Kohden wasn't on the list.

While Nihon Kohden currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.